Search research articles
Contact Us
Filters
Showing results (1-10 of 407) with videos related to
Page
of 41
Sort By:
Journal of Clinical Epidemiology
|
January 1, 1990
Quality control practices in centralized tumor registries in North America
S G Hilsenbeck
Controlled Clinical Trials
|
September 1, 1988
Early termination of a phase II clinical trial
S G Hilsenbeck
Nursing Economic$
|
August 21, 2014
A hospital system approach at decreasing falls with injuries and cost
Sylvain Trepanier, Julie Hilsenbeck
Oncology Reports
|
May 19, 2011
Pitfalls in the RNA-based PCR amplification of the CDRIII sequence for quantitation of minimal residual disease in multiple myeloma (Commentary)
Y Gazitt, S Hilsenbeck
Mechanisms of Ageing and Development
|
June 8, 2001
Array-based gene expression profiling to study aging
E Han, S G Hilsenbeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
Mothaffar Rimawi, Susan G Hilsenbeck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial
Susan G Hilsenbeck, C Kent Osborne
Blood
|
January 18, 2003
Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
Qun Liu, Susan Hilsenbeck, Yair Gazitt
Statistics in Medicine
|
January 15, 1996
Practical p-value adjustment for optimally selected cutpoints
S G Hilsenbeck, G M Clark
Journal of Chromatography. A
|
September 19, 1998
High-performance ion-exchange chromatography and adsorption of plasma proteins
S C Goheen, J L Hilsenbeck
Page
of 41
Search research articles
Search
Showing results (1-10 of 407) with videos related to
Sort By:
Page
of 41
Journal of Clinical Epidemiology
|
January 1, 1990
Quality control practices in centralized tumor registries in North America
S G Hilsenbeck
Controlled Clinical Trials
|
September 1, 1988
Early termination of a phase II clinical trial
S G Hilsenbeck
Nursing Economic$
|
August 21, 2014
A hospital system approach at decreasing falls with injuries and cost
Sylvain Trepanier, Julie Hilsenbeck
Oncology Reports
|
May 19, 2011
Pitfalls in the RNA-based PCR amplification of the CDRIII sequence for quantitation of minimal residual disease in multiple myeloma (Commentary)
Y Gazitt, S Hilsenbeck
Mechanisms of Ageing and Development
|
June 8, 2001
Array-based gene expression profiling to study aging
E Han, S G Hilsenbeck
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2012
Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
Mothaffar Rimawi, Susan G Hilsenbeck
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial
Susan G Hilsenbeck, C Kent Osborne
Blood
|
January 18, 2003
Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
Qun Liu, Susan Hilsenbeck, Yair Gazitt
Statistics in Medicine
|
January 15, 1996
Practical p-value adjustment for optimally selected cutpoints
S G Hilsenbeck, G M Clark
Journal of Chromatography. A
|
September 19, 1998
High-performance ion-exchange chromatography and adsorption of plasma proteins
S C Goheen, J L Hilsenbeck
Page
of 41